The binding receptors of Aβ: an alternative therapeutic target for Alzheimer's disease

M Xia, X Cheng, R Yi, D Gao, J Xiong - Molecular neurobiology, 2016 - Springer
Alzheimer's disease (AD) is one of the most common neurodegenerative disorders, which
causes the deterioration of memory and other cognitive abilities of the elderly. Previous lines …

The role of α7 nicotinic acetylcholine receptors and α7-specific antibodies in neuroinflammation related to Alzheimer disease

M Skok, O Lykhmus - Current Pharmaceutical Design, 2016 - ingentaconnect.com
Background: Alzheimer disease (AD) is a neurodegenerative disorder occurring in elderly
people and leading to the loss of memory, practical and speaking habits. In spite of …

[HTML][HTML] Accumulation of human full-length tau induces degradation of nicotinic acetylcholine receptor α4 via activating calpain-2

Y Yin, Y Wang, D Gao, J Ye, X Wang, L Fang, D Wu… - Scientific Reports, 2016 - nature.com
Cholinergic impairments and tau accumulation are hallmark pathologies in sporadic
Alzheimer's disease (AD), however, the intrinsic link between tau accumulation and …

Molecular simulation study of the unbinding of α-conotoxin [ϒ4E] GID at the α7 and α4β2 neuronal nicotinic acetylcholine receptors

A Suresh, A Hung - Journal of Molecular Graphics and Modelling, 2016 - Elsevier
The α7 and α4β2 neuronal nicotinic receptors belonging to the family of ligand-gated ion
channels are most prevalent in the brain, and are implicated in various neurodegenerative …

BAG2 expression dictates a functional intracellular switch between the p38-dependent effects of nicotine on tau phosphorylation levels via the α7 nicotinic receptor

ASA de Oliveira, FE Santiago, LF Balioni… - Experimental …, 2016 - Elsevier
The histopathological hallmarks present in Alzheimer's disease (AD) brain are plaques of Aβ
peptide, neurofibrillary tangles of hyperphosphorylated tau protein, and a reduction in …

α7-nicotinic acetylcholine receptors and β-amyloid peptides in Alzheimer's disease

DE Lorke, G Petroianu, M Oz - Nicotinic Acetylcholine Receptor …, 2016 - Springer
Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Neuropathological
hallmarks of AD are amyloid plaques composed of amyloid-β (Aβ), neurofibrillary tangles …

[PDF][PDF] Naturally occurring antibodies against synthetic fragment of neurotrophin receptor P75 in sera of cognitively impaired patients

M Kolarova, J Ricny, A Bartos, OM Volpina… - Age (years), 2016 - researchgate.net
Materials and Methods Participants All participants signed an informed consent. The
research was approved by the Ethics Committee of the University Hospital Kralovske …

Nicotinic Acetylcholine Receptors in the Pathophysiology of Al zheimer's Disease: The Role of Protein-Protein Interactions in Current and Future Treatment

M Skøtt Thomsen, J Tobias Andreasen… - Current …, 2016 - ingentaconnect.com
Nicotinic acetylcholine receptors (nAChRs) have been pursued for decades as potential
molecular targets to treat cognitive dysfunction in Alzheimer's disease (AD) due to their …

[图书][B] The forebrain cholinergic system and age-related decline in and compensation of attentional capacities

B Yegla - 2016 - search.proquest.com
Aging is characterized by an increase in inter-individual variability in cognitive capacity.
Slight decrements in learning and memory emerge; however, age-related shifts in …

Efeitos da nicotina em modelo in vitro de toxicidade do peptideo β-amilóide

LM Lisbôa - 2016 - lume.ufrgs.br
A Doença de Alzheimer (DA) é a mais comum desordem neurodegenerativa e a principal
causa de demência re lacionada a idade. Os números em crescimento de pessoas afetadas …